Monday, March 5, 2018

BioDuro Acquires Molecular Response

San Diego-based BioDuro, a life sciences contract research and development provider, announced this morning that it has acquired Molecular Response LLC, which provides a large collection of viable tumor specimens for the oncology market. Financial details of the buy were not announced. According to BioDuro, Molecular Response has a biobank of over 100,000 viable tumor specimens, which are used for drug discovery, oncology, and immunooncology studies. As part of thea cquisition, Thomas B. Broudy, the CEO of Molecular Response, becomes Executive Vice President, Translational Sciences & Strategy at BioDuro.

---